These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1356040)

  • 1. Recurrent neuroleptic malignant syndrome in a man with mild mental handicap.
    Bambrick M; Wilson D
    J Intellect Disabil Res; 1992 Aug; 36 ( Pt 4)():377-81. PubMed ID: 1356040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome in a case of acute post-traumatic psychosis.
    Watts D
    Br J Psychiatry; 1991 Aug; 159():277-8. PubMed ID: 1685339
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment.
    Spivak B; Weizman A; Wolovick L; Hermesh H; Tyano S; Munitz H
    Acta Psychiatr Scand; 1990 Feb; 81(2):168-9. PubMed ID: 1970216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine.
    Marshall PB; Mellman TA; Nguyen SX
    Am J Psychiatry; 2008 Nov; 165(11):1488-9. PubMed ID: 18981078
    [No Abstract]   [Full Text] [Related]  

  • 5. Case study: neuroleptic malignant syndrome without pyrexia.
    Hynes AF; Vickar EL
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):959-62. PubMed ID: 8768358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome and catatonia. A report of three cases.
    Raja M; Altavista MC; Cavallari S; Lubich L
    Eur Arch Psychiatry Clin Neurosci; 1994; 243(6):299-303. PubMed ID: 7913834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
    Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome with risperidone.
    Levin GM; Lazowick AL; Powell HS
    J Clin Psychopharmacol; 1996 Apr; 16(2):192-3. PubMed ID: 8690838
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome with hypomania and mental retardation.
    Ward MR; Corbett JA
    J Ment Defic Res; 1989 Aug; 33 ( Pt 4)():339-42. PubMed ID: 2769743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case.
    Zou D; Shao Y; Qin Z; Zhang J; Liu N; Li Z; Huang P; Chen Y
    J Forensic Leg Med; 2014 May; 24():12-4. PubMed ID: 24794843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome.
    Yasugi S; Garg V; Been G; Magoulas P
    Aust N Z J Psychiatry; 2010 Jun; 44(6):584. PubMed ID: 20482421
    [No Abstract]   [Full Text] [Related]  

  • 13. Addition of carbamazepine to long-term treatment with neuroleptics may induce neuroleptic malignant syndrome.
    Nisijima K; Kusakabe Y; Ohtuka K; Ishiguro T
    Biol Psychiatry; 1998 Nov; 44(9):930-1. PubMed ID: 9807653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome without fever after addition of oxcarbazepine to long-term treatment with amisulpride.
    Angelopoulos P; Markopoulou M; Kyamidis K; Bobotas K
    Gen Hosp Psychiatry; 2008; 30(5):482-4. PubMed ID: 18774435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K; Ishiguro T
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
    Hermesh H; Aizenberg D; Weizman A; Lapidot M; Mayor C; Munitz H
    Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent sinus arrest in association with neuroleptic malignant syndrome.
    Parry AK; Ormerod LP; Hamlin GW; Saleem PT
    Br J Psychiatry; 1994 May; 164(5):689-91. PubMed ID: 7921725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protracted neuroleptic malignant syndrome complicating long-acting neuroleptic administration.
    Legras A; Hurel D; Dabrowski G; Grenet D; Graveleau P; Loirat P
    Am J Med; 1988 Dec; 85(6):875-8. PubMed ID: 2904226
    [No Abstract]   [Full Text] [Related]  

  • 20. Clozapine, neuroleptic malignant syndrome, and pancerebellar syndrome.
    Brown TM
    Psychosomatics; 1999; 40(6):518-20. PubMed ID: 10581982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.